Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood protein may flag liver cancer spread risk after colon surgery

NCT ID NCT07177742

Recruiting now Knowledge-focused Sponsor: Mu-qing Yang Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking at a protein called PRDX1 found in tiny particles (exosomes) in blood taken from the surgical specimen of colorectal cancer patients. The goal is to see if higher levels of this protein can predict which patients will develop liver metastasis after surgery. Researchers will follow 260 patients over time to track liver metastasis and local recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a new way to identify colorectal cancer patients at high risk for liver metastasis after surgery, allowing for earlier monitoring or treatment.
What could go wrong
This is an early observational study, not a treatment trial. It only looks for a link between a protein and metastasis; it does not test any intervention. The results may not lead to a reliable test or change in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER EXOSOME LIVER METASTASES FROM COLORECTAL CANCER PATHOLOGY PEROXIDIZED REDOX PROTEIN 1

Contacts and locations

Locations

  • Shanghai Tongji Hospital, Hepatobilliary Surgery Center, Tongji University

    RECRUITING

    Shanghai, Shanghai Municipality, 200065, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.